Since being awarded his PhD by the Indian Association for the Cultivation of Science, Calcutta, Professor Banik has held positions as a Postdoctoral Fellow at Case Western Reserve University and Stevens Institute of Technology; Tenured Full Professor in Chemistry and First President’s Endowed Professor in Science & Engineering at the University of Texas-Pan American, Edinburg; an Assistant Professor in Molecular Pathology at the University of Texas M. D. Anderson Cancer Center, Houston; and a Research Assistant Professor in Chemistry & Chemical Biology at Stevens Institute of Technology, New Jersey. Since 2014, he has been the Vice President of Research & Education Development of Community Health Systems of South Texas. Professor Banik has designed, synthesized, and identified novel beta lactams derived from polyaromatic compounds as anticancer agents. He is involved in the asymmetric synthesis, biological evaluation, delivery of compounds to increase the effectiveness and mechanism of actions studies of beta lactams and polyaromatic compounds as anticancer agents. As the Principal Investigator, Professor Banik has been awarded $7.25 million in grants from the US National Institutes of Health, US National Cancer Institute, and Kleberg Foundation. He has also has more than 315 publications to his name (including peer-reviewed papers and patents, book chapters, books, perspectives, commentaries and reviews) along with approximately 460 presentation abstracts with 6000 citations. He is a reviewer of 93, editorial board member of 28, editor-in-chief of 9, founder of 4, associate editor of 4 and guest editor of 6 research journals. Furthermore, Professor Banik has presided over numerous research sessions at top conferences in the field, including one at the Nobel Prize celebration in Germany.
